Inozyme Pharma shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Inozyme Pharma (INZY) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Inozyme Pharma
Tip: Access up to 7 years of quarterly data
All positions including Inozyme Pharma held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inozyme Pharma by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.5M | 363k | 4.26 |
| 2023-09-30 | $226k | 54k | 4.20 |
| 2023-06-30 | $192k | 34k | 5.57 |
| 2022-12-31 | $13k | 12k | 1.05 |
| 2022-06-30 | $60k | 13k | 4.80 |
| 2022-03-31 | $54k | 13k | 4.07 |
| 2021-12-31 | $90k | 13k | 6.80 |
| 2021-09-30 | $192k | 17k | 11.59 |
| 2021-03-31 | $471k | 24k | 19.80 |
| 2020-12-31 | $430k | 21k | 20.63 |
| 2020-09-30 | $360k | 14k | 26.32 |